zerseos 0.5 mg/2.5 mg per 2.5 ml nebuliser solution
cipla europe nv - ipratropium bromide monohydrate; salbutamol sulfate - nebuliser solution - 0.5mg/2.5 milligram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salbutamol and sodium cromoglicate
zerseos 0.5 mg/2.5 mg per 2.5 ml nebuliser solution
azure pharmaceuticals ltd - ipratropium bromide monohydrate; salbutamol sulfate - nebuliser solution - 0.5mg/2.5 milligram(s) - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; salbutamol and sodium cromoglicate
ratio-ipratropium inhalation solution
ratiopharm inc division of teva canada limited - ipratropium bromide - solution - 250mcg - ipratropium bromide 250mcg - antimuscarinics antispasmodics
ratio-ipratropium udv solution
teva canada limited - ipratropium bromide - solution - 250mcg - ipratropium bromide 250mcg - antimuscarinics antispasmodics
ratio-ipratropium udv solution
teva canada limited - ipratropium bromide - solution - 125mcg - ipratropium bromide 125mcg - antimuscarinics antispasmodics
pms-ipratropium solution
pharmascience inc - ipratropium bromide - solution - 250mcg - ipratropium bromide 250mcg - antimuscarinics antispasmodics
mylan-ipratropium solution
mylan pharmaceuticals ulc - ipratropium bromide - solution - 250mcg - ipratropium bromide 250mcg - antimuscarinics antispasmodics
pms-salbutamol solution
pharmascience inc - salbutamol (salbutamol sulfate) - solution - 5mg - salbutamol (salbutamol sulfate) 5mg - selective beta 2-adrenergic agonists
pms-salbutamol solution
pharmascience inc - salbutamol (salbutamol sulfate) - solution - 0.5mg - salbutamol (salbutamol sulfate) 0.5mg - selective beta 2-adrenergic agonists
pms-salbutamol solution
pharmascience inc - salbutamol (salbutamol sulfate) - solution - 2mg - salbutamol (salbutamol sulfate) 2mg - selective beta 2-adrenergic agonists